Drugs / cocoa flavanols
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT04794530 Comparator | Nov 2021 → Dec 2026 expected | peripheral arterial disease | Northwestern University | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | cocoa flavanols | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04794530 ↗ |
| Route | Oral | “Participants randomized to cocoa flavanols will take two capsules daily of cocoa flavanols.” NCT04794530 ↗ |